Cancer Research and Treatment

Original Articles

Hematologic malignancy

Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥ 75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study: Seong Hyun Jeong, Seok Jin Kim, Dok Hyun Yoon, Yong Park, Hye Jin Kang, Youngil Koh, Gyeong-Won Lee, Won-Sik Lee, Deok-Hwan Yang, Young Rok Do, Min Kyoung Kim, Kwai Han Yoo, Yoon Seok Choi, Hwan Jung Yun, Jun Ho Yi, Jae-Cheol Jo, Hyeon-Seok Eom, Jae-Yong Kwak, Ho-Jin Shin, Byeong Bae Park, Shin Young Hyun, Seong Yoon Yi, Ji-Hyun Kwon, Sung Yong Oh, Hyo Jung Kim, Byeong Seok Sohn, Jong Ho Won, Se-Hyung Kim, Ho-Sup Lee, Cheolwon Suh, Won Seog Kim; Cancer Res Treat. 2022;54(4):1268-1277. Published online December 30, 2021; DOI: https://doi.org/10.4143/crt.2021.1168

Abstract PDF Supplementary Material PubReader ePub

Purpose
Febrile neutropenia (FN) can cause suboptimal treatment and treatment-related mortality (TRM) in diffuse large B-cell lymphoma (DLBCL) patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP).
Materials and methods
We conducted a prospective cohort study to evaluate the effectiveness of pegfilgrastim prophylaxis in DLBCL patients receiving R-CHOP, and we compared them with the PROCESS cohort (n=485).
Results
Since January 2015, 986 patients with DLBCL were enrolled. Pegfilgrastim was administered at least once in 930 patients (94.3%), covering 90.3% of all cycles. FN developed in 137 patients (13.9%) in this cohort (23.7% in the PROCESS cohort, p<0.001), and 4.2% of all cycles (10.2% in the PROCESS cohort, p<0.001). Dose delay was less common (≥3 days: 18.1% vs. 23.7%, p=0.015; ≥5 days: 12.0% vs. 18.3%, p=0.023) in this cohort than in the PROCESS cohort. The incidence of TRM (3.2% vs. 5.6%, p=0.047) and infection-related death (1.8% vs. 4.5%, p=0.004) was lower in this cohort than in the PROCESS cohort. The 4-year overall survival (OS) and progression-free survival (PFS) rates of the two cohorts were not different (OS: 73.0% vs. 71.9%, p=0.545; PFS: 69.5% vs. 68.8%, p=0.616). However, in patients aged ≥75 years, the 4-year OS and PFS rates were higher in this cohort than in the PROCESS cohort (OS: 49.6% vs. 33.7%, p=0.032; PFS: 44.2% vs. 30.3% p=0.047).
Conclusion
Pegfilgrastim prophylaxis is effective in the prevention of FN and infection-related death in DLBCL patients receiving R-CHOP, and it also improves OS in patients aged ≥75 years.

Citations

Citations to this article as recorded by

Sarcopenia attenuates the efficacy of PEGylated granulocyte colony-stimulating factor in preventing febrile neutropenia
Se-Il Go, Eun-Jeong Jeong, Woo Je Lee, Sungwoo Park, Mi Jung Park, Gyeong-Won Lee
Supportive Care in Cancer.2025;[Epub] CrossRef

8,295 View
305 Download
2 Web of Science
1 Crossref

Clinical Outcome of Gastric Cancer Patients with Bone Marrow Metastases: Ji Yeon Kwon, Jina Yun, Han Jo Kim, Kyoung-Ha Kim, Se-Hyung Kim, Sang-Cheol Lee, Hyun Jung Kim, Sang Byung Bae, Chan Kyu Kim, Nam Su Lee, Kyu Taek Lee, Seong Kyu Park, Jong-Ho Won, Dae Sik Hong, Hee Sook Park; Cancer Res Treat. 2011;43(4):244-249. Published online December 27, 2011; DOI: https://doi.org/10.4143/crt.2011.43.4.244

Abstract PDF PubReader ePub

PURPOSE
The prognosis of gastric cancer patients with bone marrow metastases is extremely poor. The current study was conducted to evaluate the clinical outcomes of advanced gastric cancer patients with bone marrow metastases.
MATERIALS AND METHODS
We retrospectively reviewed the medical records of 26 advanced gastric cancer patients with bone marrow metastases who were treated at Soonchunhyang University Hospital between September 1986 and February 2009.
RESULTS
The median age was 46 years (range, 24 to 61 years). All patients had poorly differentiated adenocarcinoma, including 17 signet ring cell carcinomas. The majority of the patients had thrombocytopenia, anemia, and elevated lactate dehydrogenase levels. Sixteen patients (61.5%) received palliative chemotherapy (median, 4 cycles; range, 1 to 13 cycles). The median overall survival after detection of bone marrow metastases for the cohort of patients was 37 days (95% confidence interval, 12.5 to 61.5 days). The median overall survival after detection of bone marrow involvement was 11 days in the best supportive care group (range, 2 to 34 days) and 121 days (range, 3 to 383 days) in the palliative chemotherapy group (p<0.001). The causes of death were tumor progression (11 patients, 45%), brain hemorrhage (6 patients, 25%), infection (5 patients, 21%), and disseminated intravascular coagulation (1 patient, 4%). There were no chemotherapy-related deaths.
CONCLUSION
Palliative chemotherapy could be considered in advanced gastric cancer patients with bone marrow metastases as a treatment option.

Citations

Citations to this article as recorded by

Bone marrow metastasis of ovarian cancer: A two‑center retrospective study and literature review
Tomonori Yamada, Junya Nakajima, Yuuki Ooba, Akira Yabuno, Yuri Yano, Masaki Yoshida, Mitsutake Yano, Masanori Yasuda, Eiji Kobayashi
Molecular and Clinical Oncology.2025;[Epub] CrossRef
FDP/FIB ratio serves as a novel biomarker for diagnosing bone marrow invasion in gastric cancer and predicting patient prognosis
Xi Yan, Yinghao Niu, Xingxiao Yang, Riyang Zhao, Wenxuan Cui, Xiujuan Guo, Jinyan Zhang, Ming Ma
Scientific Reports.2025;[Epub] CrossRef
Diagnostic Challenges in Detecting Gastrointestinal Cancer Presented with Bicytopenia, Report of Two Cases and Review of Literature
Zohreh Mohammadi, Zohreh Ehsani, Versa Omrani-Nava
Journal of Clinical Research in Paramedical Sciences.2025;[Epub] CrossRef
Bone Marrow Metastasis in Non-hematological Malignancies: Data From a Tertiary Care Hospital in North India
Satish Kumar, Kaushal Kumar, Rawi Agrawal, Vijayanand Choudhary
Cureus.2025;[Epub] CrossRef
Rare Case of Adenocarcinoma of Stomach with Disseminated Bone Marrow Metastasis
Akanksha Palo, Harish Goyal, Dhanapathi Halanaik
Indian Journal of Nuclear Medicine.2025; 40(2): 122. CrossRef
Long-term survival of a patient with gastric cancer with bone marrow metastasis receiving S-1 plus oxaliplatin beyond three years: a case report and literature review
Hirotaka Suto, Yumiko Inui, Atsuo Okamura
Frontiers in Oncology.2024;[Epub] CrossRef
Comprehensive review of solid tumor bone marrow metastasis
Lanxin Zhang, Fengxi Chen, Lingzhi Xu, Ning Li, Qiping Zhuo, Yijin Guo, Xueqing Wang, Meijie Wen, Zuowei Zhao, Man Li
Critical Reviews in Oncology/Hematology.2024; 194: 104248. CrossRef
Mechanism and clinical progression of solid tumors bone marrow metastasis
Ruohan Yang, Lin Jia, Jiuwei Cui
Frontiers in Pharmacology.2024;[Epub] CrossRef
Is Bone Marrow Metastasis in Gastric Cancer Adequate for Best Supportive Care Decisions? Or is There Still a Chance?
Berkan Karabuğa, Ergin Aydemir, Fatih Yıldız, Necati Alkış
Acta Haematologica Oncologica Turcica.2024;[Epub] CrossRef
Case Report: Prompt Response to Savolitinib in a Case of Advanced Gastric Cancer With Bone Marrow Invasion and MET Abnormalities
Wen Ye, Liping He, Lei Su, Zhousan Zheng, Meilin Ding, Sheng Ye
Frontiers in Oncology.2022;[Epub] CrossRef
Bone Metastasis From Gastric Adenocarcinoma—What Are the Risk Factors and Associated Survival? A Large Comprehensive Population-Based Cohort Study
Lei Huang, Yajie Zhao, Yan Shi, Weiguo Hu, Jun Zhang
Frontiers in Oncology.2022;[Epub] CrossRef
Gastric Cancer With Multiple Bone Metastases: An Uncommon Primary Presentation
João Barbosa-Martins, Salomé Marques, Olinda Miranda, Bárbara Lima, Jorge Cotter
Cureus.2022;[Epub] CrossRef
Docetaxel and Fluorouracil as First-Line Therapy for Gastric Cancer with Bone Marrow Metastasis and Disseminated Intravascular Coagulation
Zhai Xiaohui, Li Shanshan, Cao Taiyuan, Du Ge, Yu Hongen, Shi Lishuo, Lin Xiaoru, Hong Wanjia, Xiao Jian
Future Oncology.2022; 18(35): 3875. CrossRef
The influence of serum sodium concentration on prognosis in patients with urothelial carcinoma treated by radical cystectomy
Yan Zhang, Zuojun Wang, Xue Yang, Qingchun Zhao, Long He
Medicine.2022; 101(52): e31973. CrossRef
Access to Palliative Care Services and Clinical Outcomes of Patients With Solid Malignancy-Associated Myelophthisis in a Resource-Limited Setting
Cesar Vargas-Serafin, Aldo A. Acosta-Medina, Kevin Teran-De-la-Sancha, Jesus Delgado-de-la-Mora, María T. Bourlon, Christianne Bourlon
American Journal of Hospice and Palliative Medicine®.2021; 38(8): 932. CrossRef
Disseminated Bone Marrow Carcinomatosis Due to Malignant Melanoma of Unknown Primary Origin
Kotaro Matsumoto, Kentaro Kikuchi, Tomohiro Kikuyama, Go Saito, Takako Adachi, Ayako Watanabe, Hiromichi Tsunashima, Takayuki Tsujikawa, Ken Sato, Shinpei Doi
Internal Medicine.2021; 60(21): 3469. CrossRef
Survival Outcomes and Treatment Decision by Human Papillomavirus Status Among Patients With Stage IVC Head and Neck Squamous Cell Carcinoma
Ping Zhou, Yi-Feng Yu, Chen-Lu Lian, Jun Wang, Ren-Gong Zhuo, San-Gang Wu
Frontiers in Oncology.2021;[Epub] CrossRef
Gastric Signet Ring Cell Carcinoma with Metastasis to the Bone and Bone Marrow in a Patient with 12-Year-Disease-Free Interval and Unusually Long Survival Time
Hyung Woo Kim, Mi Jin Gu, Jong Ho Lee
Laboratory Medicine Online.2021; 11(4): 305. CrossRef
Signet-ring cells in the bone marrow as an indication of cryptic metastasis of breast carcinoma
Shuang Ma, Bruce D. Leckey Jr, Wan-Lin Zhang, Hong-Tao Xu, Lian-He Yang, Endi Wang
Medicine.2019; 98(11): e14883. CrossRef
Weighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS study
Giovanni Fucà, Luigi Mariani, Salvatore Lo Vullo, Giulia Galli, Rossana Berardi, Massimo Di Nicola, Claudio Vernieri, Daniele Morelli, Katia Dotti, Ilaria Fiordoliva, Silvia Rinaldi, Cecilia Gavazzi, Filippo Pietrantonio, Marco Platania, Filippo de Braud
Scientific Reports.2019;[Epub] CrossRef
Malignant Pleural Mesothelioma with Bone Marrow Metastases
Hiroaki Ihara, Norihiro Harada, Naoko Shimada, Koichiro Kanamori, Takuo Hayashi, Toshimasa Uekusa, Kazuhisa Takahashi
Internal Medicine.2018; 57(17): 2541. CrossRef
An unusual hematological presentation of gastric adenocarcinoma
Hendra Koncoro, Eddy Setijoso, Findy Prasetiawaty, Maisie ME Johan, Renaningtyas Tambun
Gastroenterology & Hepatology: Open Access.2018;[Epub] CrossRef
Clinical outcome of 30 patients with bone marrow metastases
Min Hang Zhou, Zhi Hong Wang, Hong Wei Zhou, Mo Liu, Yong Jian Gu, Jun Zhong Sun
Journal of Cancer Research and Therapeutics.2018; 14(Suppl 2): S512. CrossRef
Recurrent gastric cancer metastasizing to the bone marrow: A case report of a rare presentation
Ernest Fonocho, Nail Aydin, Srini Reddy, Subhasis Misra
International Journal of Surgery Case Reports.2017; 37: 165. CrossRef
Clinical Outcomes of Endoscopic Hemostasis for Bleeding in Patients with Unresectable Advanced Gastric Cancer
In Ji Song, Hyun Ju Kim, Ji Ae Lee, Jun Chul Park, Sung Kwan Shin, Sang Kil Lee, Yong Chan Lee, Hyunsoo Chung
Journal of Gastric Cancer.2017; 17(4): 374. CrossRef
Generalized high bone mineral density on bone density scanning: a case of gastric carcinoma with bone metastasis
Pianpian Fan, Qin Wang, Chunyan Lu, Decai Chen
Postgraduate Medicine.2017; 129(2): 299. CrossRef
A case of disseminated carcinomatosis of the bone marrow originating from gastric cancer 3 years after intraperitoneal chemotherapy against peritoneal carcinomatosis
Takayuki Okuno, Hironori Yamaguchi, Joji Kitayama, Hironori Ishigami, Takeshi Nishikawa, Junichiro Tanaka, Toshiaki Tanaka, Tomomichi Kiyomatsu, Keisuke Hata, Hiroaki Nozawa, Kazushige Kawai, Shinsuke Kazama, Soichiro Ishihara, Eiji Sunami, Toshiaki Watan
World Journal of Surgical Oncology.2016;[Epub] CrossRef
Pathological findings in a case of bone marrow carcinosis due to gastric cancer complicated by disseminated intravascular coagulation and thrombotic microangiopathy
Yoshinobu Seki, Kunihiko Wakaki
International Journal of Hematology.2016; 104(4): 506. CrossRef
Endoscopic Management of Tumor Bleeding from Inoperable Gastric Cancer
Young-Il Kim, Il Ju Choi
Clinical Endoscopy.2015; 48(2): 121. CrossRef
An Unusual Case of Gastric Cancer with Bone Marrow Metastases and Embolic Phenomena as Initial Presentation
Harjot Kaur, Appalanaidu Sasapu, Jeanette Ramos, Rangaswamy Govindarajan
Journal of Gastrointestinal Cancer.2015; 46(4): 413. CrossRef
Development and Validation of a Prognostic Score to Predict Survival in Adult Patients With Solid Tumors and Bone Marrow Metastases
Wen-Chi Chou, Kun-Yun Yeh, Meng-Ting Peng, Jen-Shi Chen, Hung-Ming Wang, Yung-Chang Lin, Chien-Ting Liu, Shau-Hsuan Li, Pei-Hung Chang, Cheng-Hsu Wang, Ping-Tsung Chen, Yu-Shin Hung, Chang-Hsien Lu
Medicine.2015; 94(23): e966. CrossRef
Her-2 Positive Gastric Cancer Presented with Thrombocytopenia and Skin Involvement: A Case Report
Deniz Arslan, Mukremin Uysal, Ali Murat Tatlı, Seyda Gunduz, Sema Sezgin Goksu, Cumhur İbrahim Başsorgun, Hasan Senol Coskun, Hakan Bozcuk, Burhan Savaş
Case Reports in Oncological Medicine.2014; 2014: 1. CrossRef
Gastric Carcinoma with Bone Marrow Metastasis: A Case Series
Ahmet Şiyar Ekinci, Öznur Bal, Tahsin Özatlı, İbrahim Türker, Onur Eşbah, Ayşe Demirci, Burçin Budakoğlu, Ülkü Yalçıntaş Arslan, Emrah Eraslan, Berna Öksüzoğlu
Journal of Gastric Cancer.2014; 14(1): 54. CrossRef
Gastric cancer with initial bone metastasis: A distinct group of diseases with poor prognosis
Yu Jung Kim, Se Hyun Kim, Jin Won Kim, Jeong-Ok Lee, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee, Keun-Wook Lee
European Journal of Cancer.2014; 50(16): 2810. CrossRef
Methylated TIMP-3 DNA in Body Fluids Is an Independent Prognostic Factor for Gastric Cancer
Jiang-Liu Yu, Ping Lv, Jing Han, Xin Zhu, Lian-Lian Hong, Wang-Yu Zhu, Xin-Bao Wang, Yi-Chen Wu, Pei Li, Zhi-Qiang Ling
Archives of Pathology & Laboratory Medicine.2014; 138(11): 1466. CrossRef
Prognostic Factors in Adult Patients with Solid Cancers and Bone Marrow Metastases
Yu-Shin Hung, Wen-Chi Chou, Tai-Di Chen, Tse-Ching Chen, Po-Nan Wang, Hung Chang, Hung-Chih Hsu, Wen-Chi Shen, Wei-Hong Cheng, Jen-Shi Chen
Asian Pacific Journal of Cancer Prevention.2014; 15(1): 61. CrossRef
Preoperative serum pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen level predicts postoperative distant metastasis in patients with non-small-cell lung cancer†
Yumi Tanaka, Tatsuya Yoshimasu, Shoji Oura, Yoshimitsu Hirai, Mitsumasa Kawago, Masako Ikeda, Yoshitaka Okamura
European Journal of Cardio-Thoracic Surgery.2013; 44(3): 539. CrossRef

13,436 View
108 Download
37 Crossref

First
Prev
Page of 1
Next
Last

Search